575 results on '"Igarashi, Ataru"'
Search Results
2. Reduction in all-cause medical and caregiving costs through innovative health awareness projects in a rural area in Japan: a retrospective cohort study
3. The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan
4. A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices
5. Cost-effectiveness analysis of NVX-CoV2373 COVID-19 vaccination for elderly people in Japan
6. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
7. Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives
8. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
9. Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation
10. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan
11. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
12. Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine
13. Three-year outcomes of robotic gastrectomy versus laparoscopic gastrectomy for the treatment of clinical stage I/II gastric cancer: a multi-institutional retrospective comparative study
14. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer
15. High-fiber liquid diet for chronic constipation: An exploration from healthcare providers' survey results
16. Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis
17. Cost-effectiveness of digital therapeutics for essential hypertension
18. A targeted review of worldwide indirect treatment comparison (ITC) guidelines and best practices
19. Correction: Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives
20. Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan
21. Do health preferences differ among Asian populations? A comparison of EQ-5D-5L discrete choice experiments data from 11 Asian studies
22. Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy
23. Drug Utilization and Medical Cost Study Focusing on Moisturizers in Cancer Patients Treated with Molecular Targeted Therapy: A Retrospective Observational Study Using Data from a Japanese Claims Database
24. Health-Related Quality of Life during COVID-19 Pandemic: Assessing Impacts of Job Loss and Financial Support Programs in Japan
25. Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data
26. Improvement in prescriptions while maintaining overall health outcomes: a prospective observational study conducted in Japanese facilities for older people
27. Health state utilities of patients with hepatitis B and C and hepatitis-related conditions in Japan
28. Comparing the effects of biguanides and dipeptidyl peptidase-4 inhibitors on cardio-cerebrovascular outcomes, nephropathy, retinopathy, neuropathy, and treatment costs in diabetic patients.
29. Cost-Effectiveness Analysis of Omalizumab for Severe Allergic Asthma in Japan Using Real-World Evidence
30. Effects of Lusutrombopag on Post-invasive Procedural Bleeding in Thrombocytopenic Patients with Chronic Liver Disease
31. The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
32. Cost-Effectiveness Analysis of Percutaneous Patent Foramen Ovale Closure Preventing Secondary Ischemic Stroke in Japan
33. Cost-effectiveness of baloxavir marboxil compared to laninamivir for the treatment of influenza in Japan
34. Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer
35. How Do Respondents Interpret and View the EQ-VAS? A Qualitative Study of Three Asian Populations
36. Cost-effectiveness of surveillance intervals after curative resection of colorectal cancer.
37. Optimal age to discontinue long-term surveillance of intraductal papillary mucinous neoplasms: comparative cost-effectiveness of surveillance by age.
38. Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
39. Impact on Quality of Life by Clostridioides difficile Infections among Hospitalized Patients in Japan
40. Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment
41. The potential economic impact of the updated COVID-19 mRNA fall 2023 vaccines in Japan
42. Malnutrition-Related Health Care Cost in Japan : An Analysis of Health Insurance Claims Data
43. Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis
44. Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology
45. Cost-utility analysis of a ‘vonoprazan-first’ strategy versus ‘esomeprazole- or rabeprazole-first’ strategy in GERD
46. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan.
47. Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 Vaccine
48. Current Usage and Discrepancies in the Adoption of Health-related IoT/Apps among Working Women in Japan: A Large-scale Internet Cross-sectional Survey (Preprint)
49. Current Usage and Discrepancies in the Adoption of IoT/Apps for Managing Working Women's Health: Findings from a Large-scale Internet Survey in Japan (Preprint)
50. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.